Evidence map›Paper›PMID 36271003›Full record

ArticleNature communications2022

Antibiotic polymyxin arranges lipopolysaccharide into crystalline structures to solidify the bacterial membrane.

Selen Manioglu, Seyed Majed Modaresi, Noah Ritzmann, Johannes Thoma, Sarah A Overall, Alexander Harms, Gregory Upert, Anatol Luther, Alexander B Barnes, Daniel Obrecht and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
7.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 108 citations in OpenAlex.

  1. Article
  2. Article
  3. LPS in gram-negative bacterial growth and physiology: outside but fully integrated.Microbiology and molecular biology reviews : MMBR · 2026
    Review
  4. A functionally selectedApplied and environmental microbiology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Bacterial cell envelope-targeting antibiotics.Nature reviews. Microbiology · 2026
    Review
  11. Article
  12. Review
  13. A functionally selectedbioRxiv : the preprint server for biology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Selen ManiogluDepartment of Biosystems Science and Engineering, Eidgenössische Technische Hochschule (ETH) Zürich, Mattenstrasse 26, Basel, Switzerland.
Seyed Majed ModaresiBiozentrum, University of Basel, Spitalstrasse 41, Basel, Switzerland.ORCID http://orcid.org/0000-0001-9747-9748
Noah RitzmannDepartment of Biosystems Science and Engineering, Eidgenössische Technische Hochschule (ETH) Zürich, Mattenstrasse 26, Basel, Switzerland.
Johannes ThomaDepartment of Chemistry and Molecular Biology, University of Gothenburg, Göteborg, Sweden.ORCID http://orcid.org/0000-0003-3584-8274
Sarah A OverallLaboratory of Physical Chemistry, ETH Zurich, Zurich, Switzerland.
Alexander HarmsBiozentrum, University of Basel, Spitalstrasse 41, Basel, Switzerland.ORCID http://orcid.org/0000-0003-2106-1286
Gregory UpertSpexis AG, Allschwil, Switzerland.
Anatol LutherBachem AG, Bubendorf, Switzerland.
Alexander B BarnesLaboratory of Physical Chemistry, ETH Zurich, Zurich, Switzerland.
Daniel ObrechtSpexis AG, Allschwil, Switzerland.
Daniel J MüllerDepartment of Biosystems Science and Engineering, Eidgenössische Technische Hochschule (ETH) Zürich, Mattenstrasse 26, Basel, Switzerland. daniel.mueller@bsse.ethz.ch.ORCID http://orcid.org/0000-0003-3075-0665
Sebastian HillerBiozentrum, University of Basel, Spitalstrasse 41, Basel, Switzerland. sebastian.hiller@unibas.ch.ORCID http://orcid.org/0000-0002-6709-4684
Board of the Swiss Federal Institutes of Technology · CHUniversity of Basel · CHETH Zurich · CHBachem (Switzerland) · CHUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymyxins are last-resort antibiotics with potent activity against multi-drug resistant pathogens. They interact with lipopolysaccharide (LPS) in bacterial membranes, but mechanistic details at the molecular level remain unclear. Here, we characterize the interaction of polymyxins with native, LPS-containing outer membrane patches of Escherichia coli by high-resolution atomic force microscopy imaging, along with structural and biochemical assays. We find that polymyxins arrange LPS into hexagonal assemblies to form crystalline structures. Formation of the crystalline structures is correlated with the antibiotic activity, and absent in polymyxin-resistant strains. Crystal lattice parameters alter with variations of the LPS and polymyxin molecules. Quantitative measurements show that the crystalline structures decrease membrane thickness and increase membrane area as well as stiffness. Together, these findings suggest the formation of rigid LPS-polymyxin crystals and subsequent membrane disruption as the mechanism of polymyxin action and provide a benchmark for optimization and de novo design of LPS-targeting antimicrobials.

Indexed as

Escherichia coli InfectionsPolymyxinsAnti-Bacterial AgentsEscherichia coliHumansLipopolysaccharidesPolymyxin BAnti-Bacterial AgentsLipopolysaccharidesPolymyxin BPolymyxins

Identifiers

PMID36271003
PMCPMC9587031
OpenAlexW4306983712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.